当前位置:首页 - 行情中心 - 荣昌生物(688331) - 财务分析

荣昌生物

(688331)

  

流通市值:105.77亿  总市值:367.47亿
流通股本:1.62亿   总股本:5.64亿

荣昌生物(688331)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年第一季度实现净利润-2.54亿元,每股收益-0.46元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年第一季度最新股东权益177142.51万元,未分配利润-457601.57万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年第一季度最新总资产530734.50万元,负债353592.00万元。

利润表
报告期2025-03-312024-12-312024-09-302024-06-30
营业总收入525,968,624.061,716,861,688.031,208,874,280.23741,756,779.89
营业总成本783,824,467.593,227,249,148.212,316,244,667.131,544,261,566.81
营业利润-249,746,497.51-1,455,655,359.91-1,055,861,790.96-771,548,100.97
利润总额-254,144,470.06-1,468,360,802.55-1,071,426,638.9-780,459,767.69
净利润-254,144,470.06-1,468,360,802.55-1,071,426,638.9-780,459,767.69
其他综合收益11,992,969.57-30,878,101.93-42,366,321.69-25,993,401.13
综合收益总额-242,151,500.49-1,499,238,904.48-1,113,792,960.59-806,453,168.82
资产负债表
报告期2025-03-312024-12-312024-09-302024-06-30
流动资产合计2,160,787,697.472,289,796,373.312,524,007,322.362,493,879,928.93
非流动资产合计3,146,557,350.553,208,721,795.513,188,706,090.643,260,659,117.84
资产总计5,307,345,048.025,498,518,168.825,712,713,4135,754,539,046.77
流动负债合计2,344,955,090.42,178,296,653.171,860,787,964.011,638,720,742.08
非流动负债合计1,190,964,862.551,334,020,894.711,483,244,910.181,451,208,765.9
负债合计3,535,919,952.953,512,317,547.883,344,032,874.193,089,929,507.98
归属于母公司股东权益合计1,771,425,095.071,986,200,620.942,368,680,538.812,664,609,538.79
股东权益合计1,771,425,095.071,986,200,620.942,368,680,538.812,664,609,538.79
负债和股东权益合计5,307,345,048.025,498,518,168.825,712,713,4135,754,539,046.77
现金流量表
报告期2025-03-312024-12-312024-09-302024-06-30
经营活动现金流入小计479,999,884.371,632,499,851.971,222,172,614.37633,606,485.86
经营活动现金流出小计668,315,017.452,746,803,365.172,057,275,681.251,453,776,023.18
经营活动产生的现金流量净额-188,315,133.08-1,114,303,513.2-835,103,066.88-820,169,537.32
投资活动现金流入小计159,851,0251,023,796,795.04540,895,187.7613,996,781.48
投资活动现金流出小计186,638,909.831,272,031,866.7966,701,645.19348,567,788.24
投资活动产生的现金流量净额-26,787,884.83-248,235,071.66-425,806,457.43-334,571,006.76
筹资活动现金流入小计530,696,523.81,805,605,239.321,316,625,345.481,176,645,853.97
筹资活动现金流出小计353,972,558.77412,636,435.24114,566,898.6477,150,337.77
筹资活动产生的现金流量净额176,723,965.031,392,968,804.081,202,058,446.841,099,495,516.2
汇率变动对现金及现金等价物的影响-2,367,997.432,547,892.84-5,694,629.931,835,202.01
现金及现金等价物净增加额-40,747,050.3132,978,112.06-64,545,707.4-53,409,825.87
期末现金及现金等价物余额718,782,993.11759,530,043.42662,006,223.96673,142,105.49
最新报告期:2025-05-02
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
浦银国际证券阳景,胡泽宇-1.90-1.40-0.202025-05-02
浙商证券郭双喜-1.50-0.590.332025-04-30
国投证券马帅,连国强-1.90-0.710.482025-04-29
浦银国际证券阳景,胡泽宇-1.90-1.40-0.202025-04-14
光大证券王明瑞-1.87-0.790.322025-04-11
TOP↑